DE69434093D1 - Substanz mit immunonodulierender wirkung und zur verringerung der disfunktion des gewebezellenregelungssystems - Google Patents

Substanz mit immunonodulierender wirkung und zur verringerung der disfunktion des gewebezellenregelungssystems

Info

Publication number
DE69434093D1
DE69434093D1 DE69434093T DE69434093T DE69434093D1 DE 69434093 D1 DE69434093 D1 DE 69434093D1 DE 69434093 T DE69434093 T DE 69434093T DE 69434093 T DE69434093 T DE 69434093T DE 69434093 D1 DE69434093 D1 DE 69434093D1
Authority
DE
Germany
Prior art keywords
immunonodulating
disfunction
substance
reducing
effect
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69434093T
Other languages
English (en)
Other versions
DE69434093T2 (de
Inventor
Tamara Vasilievna Vorobieva
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from RU94004903A external-priority patent/RU2035182C1/ru
Priority claimed from RU94004904A external-priority patent/RU2035181C1/ru
Application filed by Individual filed Critical Individual
Publication of DE69434093D1 publication Critical patent/DE69434093D1/de
Application granted granted Critical
Publication of DE69434093T2 publication Critical patent/DE69434093T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/36—Arsenic; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/28—Mercury; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Toxicology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DE69434093T 1994-02-18 1994-06-15 Substanz mit immunonodulierender wirkung und zur verringerung der disfunktion des gewebezellenregelungssystems Expired - Fee Related DE69434093T2 (de)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
RU94004904 1994-02-18
RU94004903A RU2035182C1 (ru) 1994-02-18 1994-02-18 Противоопухолевые и иммуномодулирующие средства и способы лечения онкологических больных, кожных заболеваний и трофических язв
RU94004904A RU2035181C1 (ru) 1994-02-18 1994-02-18 Средство для лечения лейкозов и способ лечения лейкозов
RU94004903 1994-02-18
PCT/RU1994/000128 WO1995022336A1 (fr) 1994-02-18 1994-06-15 Agent immunomodulateur et reducteur du dysfonctionnement du systeme de regulation de la propagation de cellules tissulaires

Publications (2)

Publication Number Publication Date
DE69434093D1 true DE69434093D1 (de) 2004-11-25
DE69434093T2 DE69434093T2 (de) 2006-03-09

Family

ID=26653774

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69434093T Expired - Fee Related DE69434093T2 (de) 1994-02-18 1994-06-15 Substanz mit immunonodulierender wirkung und zur verringerung der disfunktion des gewebezellenregelungssystems

Country Status (5)

Country Link
US (1) US5889048A (de)
EP (1) EP0804928B1 (de)
CA (1) CA2183547C (de)
DE (1) DE69434093T2 (de)
WO (1) WO1995022336A1 (de)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU751932B2 (en) 1997-10-15 2002-08-29 Polarx Biopharmaceuticals, Inc. Compositions and methods for the treatment of primary and metastatic neoplastic diseases using arsenic compounds
EP1964557B1 (de) 1997-11-10 2013-01-02 Memorial Sloan-Kettering Cancer Center Verfahren zur Herstellung von Arsentrioxidformulierungen
CN1233476A (zh) 1998-04-24 1999-11-03 陆道培 治疗急性白血病的药物及其制备方法
WO2003086424A1 (en) * 2002-04-10 2003-10-23 Korea Microbiological Laboratories, Ltd. Pharmaceutical composition comprising arsenite for the treatment of malignancy
FR2838965B1 (fr) * 2002-04-26 2004-06-25 Centre Nat Rech Scient Therapie par l'arsenic du syndrome autoimmunlymphoproliferatif de type apls chez la souris comme chez l'homme
US8394422B2 (en) * 2002-04-26 2013-03-12 Centre National De La Recherche Scientifique (Cnrs) Arsenic therapy for autoimmune and/or inflammatory diseases in mice and humans
WO2006024489A2 (en) * 2004-08-30 2006-03-09 Interstitial Therapeutics Methods and compositions for the treatment of cell proliferation
US20070254037A1 (en) * 2004-12-15 2007-11-01 Youri Popowski Methods and Compositions for the Treatment of Cell Proliferation
EP1721615A1 (de) * 2005-05-09 2006-11-15 Komipharm International Co., Ltd. Pharmazeutische Zusammensetzung enthaltend Natrium- oder Kaliumarsenit zur Behandlung von Urogenitalkrebs und seinen Metastasen
US20060292243A1 (en) * 2005-06-24 2006-12-28 Shao-Chi Hsin Arsenic compounds for the treatment of the arsenic-sensitive blast-cell related diseases
US20080233207A1 (en) * 2006-01-04 2008-09-25 Sheptovitsky Yelena G Injectable and Infusable Mercury Compositions and Methods for Treating Cancer
US20070154567A1 (en) * 2006-01-04 2007-07-05 Sheptovitsky Yelena G Use of mercury to treat cancer
US8945505B2 (en) 2007-02-02 2015-02-03 Panaphix, Inc. Use of arsenic compounds for treatment of pain and inflammation
US20120045520A1 (en) * 2008-08-21 2012-02-23 Sang Bong Lee Pharmaceutical composition comprising arsenite for the treatment of malignancy
TR201905548T4 (tr) * 2009-09-10 2019-05-21 Kominox Inc Kanser kök hücresi hedefli ve ilaç dirençli kanser terapisi.

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4104373A (en) * 1969-06-20 1978-08-01 Richard Sichert Therapeutical composition
IL63928A (en) * 1980-10-04 1985-02-28 Byk Gulden Lomberg Chem Fab Pharmaceutical compositions comprising beta-diketone metal complexes,some such novel complexes and their preparation
FR2539993A1 (fr) * 1983-01-28 1984-08-03 Darcheux Mario Baume agissant sur les plaies cancereuses
GB8328218D0 (en) * 1983-10-21 1983-11-23 Johnson Matthey Plc Oral compositions
FR2572284B1 (fr) * 1984-10-26 1987-01-09 Merieux Inst Nouveau medicament modulateur de l'immunite a base de diethyldithiocarbamate et son procede de preparation
DE3724259A1 (de) * 1987-07-22 1989-02-02 Friedrich Bruenen Mittel zur bekaempfung von haarausfall, insbesondere von androgenetischem haarausfall
BR9102660A (pt) * 1991-06-25 1993-01-26 Jair Vilaca Castro Produto profilatico

Also Published As

Publication number Publication date
US5889048A (en) 1999-03-30
EP0804928A4 (de) 1999-01-13
WO1995022336A1 (fr) 1995-08-24
EP0804928B1 (de) 2004-10-20
CA2183547C (en) 2002-05-14
EP0804928A1 (de) 1997-11-05
DE69434093T2 (de) 2006-03-09
CA2183547A1 (en) 1995-08-24

Similar Documents

Publication Publication Date Title
ATE349428T1 (de) Prostaglandinagoniste und deren verwendung zur behandlung von knochenerkrankungen
DE69434093D1 (de) Substanz mit immunonodulierender wirkung und zur verringerung der disfunktion des gewebezellenregelungssystems
DE69622074T2 (de) Cystin-Silikon-Copolymere und deren Verwendung zur Behandlung von keratinischen Materialien
DE69528721T2 (de) Verwendung von antimykotischen Mitteln und von halogenierten antibakteriellen Mitteln zur Verringerung des Haarausfalls
DE69422442T2 (de) Chirurgischer Verband und eine Haftzusammensetzung dafür
PT964849E (pt) Derivados de sulfonilureia e sua utilizacao no controlo da actovidade da interleucina-1
DE69716189T2 (de) Verwendung von Melatonin-Derivaten zur Hautdepigmentierung sowie diese enthaltende Präparate
DE68928051D1 (de) Behandlung von humanem Kollagen und Verwendung als Auto-Implantat
DE69533997D1 (de) System zur Steuerung der Verteilung und Benutzung von Digitalwerken
DE69407552D1 (de) Trockner zur kontinuierlichen trocknungs- und konditionierungsbehandlung von häuten oder geweben
BR9707318A (pt) Composição microbicida e método para controlar o crescimento de pelos menos um microorganismo
DE69515070T2 (de) Zusammensetzung auf der Basis von alpha-Pyronen zur Induzierung und Stimulierung des Haarwachstums und/oder zur Verlangsamung des Haarausfalls und ihre Verwendung
DE69513307T4 (de) Zusammensetzung und verwendung
ATE216979T1 (de) Anwendung von amides zur kontrolle des biobewuchses
DE69414916D1 (de) Mittel zur Entfernung von farbigem Material und seine Verwendung
DE69636792D1 (de) Verwendung von l-carnitine und acyl derivaten zur senkung des ceramidspiegels
DE60017133D1 (de) Naphthochinonderivate und ihre verwendung zur behandlung und kontrolle von tuberkulose
ATE301472T1 (de) Wachstumsfaktoren enthaldende therapeutische homöopathische verdünnungen und verwendung
ATE218862T1 (de) Verwendung von 1-hydroxy-2-pyridonen zur behandlung von hautinfektionen
NO951825D0 (no) Vannbasert hårbehandlingspreparat og anvendelse av dette
DE69624214D1 (de) Hormonale medikamente und deren verwendung zur behebung von östrogenmangelerscheinungen
DE69732875D1 (de) Herstellung und Verwendung von L-Ribose-Isomerase
PT935692E (pt) Tratamento de tecido com celulase e oxidoredutase
DE69214299D1 (de) Verwendung von alkylpolyglycosiden und/oder 0-acylierte glukosederivate zur behandlung des haarausfalls
DE69822276D1 (de) Kräuter formulierung mit therapeutischer und kosmetischer verwendung zur behandlung von allgemeinen hauterkrankungen

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee